Lenacapavir could be a gamechanger in the fight against infection. But US funding cuts have thrown the rollout of the ...

Gilead Sciences on Thursday reported a first-quarter profit, but revenue was flat, as higher sales of drugs for HIV and liver ...

The Center in Asbury Park wants people to "Come Early, Stand Proud, and Walk Strong" on May 4 for the New Jersey AIDS Walk ...

“Trump ’47 should not allow Trump ’45’s massive public health achievement to be cancelled — especially when that legacy will ...

A modeling study looked at how anticipated cuts to international HIV funding would affect the rate of new cases and ...

The Trump Administration has gutted many areas of healthcare funding and research, especially in infectious diseases. One ...

Young people still face high HIV risks despite PrEP Learn why prevention efforts must center Gen Z for a healthier future.

A new report shows a sharp rise in STIs in Houston and Harris County, with the city's rates now exceeding statewide averages ...

Serhat Gumrukcu, 42, hired Jerry Banks through two associates to murder Gregory Davis in 2018, in Vermont, U.S. Attorney's ...

Moving misbranded and adulterated HIV drugs from the black market to retail pharmacies and HIV patients was a $60 million ...

Restaurants across the Indianapolis area will donate a portion of their April 24 sales to an HIV/AIDS service center.

Despite steep budget and staffing cuts at the FDA in recent weeks and other headwinds, Gilead CEO Daniel O’Day assured investors that the pharma’s plans and preparations for lenacapavir’s launch ...